Webinar: Orange Book listing sheets under the microscope
Key Considerations for Reshoring U.S. Drug Manufacturing
Drug Pricing Initiatives During the Trump Presidency
Podcast: IP Life Sciences Landscape: Aiding Orange and Purple Book Patent Owners in Developing PTAB Survival Skills
Patent law in Europe: What pharmaceutical companies need to know
EU excessive pricing laws
Polsinelli Podcast - Generic Drugs to Market - What's the Climate in 2014?
RELYING ON A FEDERAL CIRCUIT DECISION THAT INVALIDATED FOR LACKING AN ADEQUATE WRITTEN DESCRIPTION A PATENT FROM WHICH THE PATENTS-IN-SUIT DESCEND, THE COURT DENIED PLAINTIFF’S MOTION FOR A PRELIMINARY INJUNCTION FOR FAILING...more
WHERE THE DEFENDANTS SOUGHT OUT A CLAIM CONSTRUCTION IN THE DISTRICT COURT, THE FEDERAL CIRCUIT AFFIRMED A FINDING OF NON-INFRINGEMENT, AND WHERE THE DEFENDANT DID NOT SEEK A CLARIFYING CLAIM CONSTRUCTION, THE FEDERAL CIRCUIT...more
PLAINTIFF’S DISCLAIMER OF CLAIMS FOUND INVALID BY THE PTAB MOOTED ANY CONTROVERSY BEFORE THE APPELLATE COURT ASSOCIATED WITH THAT PATENT, AND A SECOND PATENT-IN-SUIT WAS NOT INVALID BECAUSE THE DISTRICT COURT DID NOT ERR IN...more
Case Name: Nuvo Pharms. (Ir.) Designated Activity Co. v. Dr. Reddy’s Labs. Inc., 923 F.3d 1368, 2019 U.S. App. LEXIS 14345 (Fed. Cir. May 15, 2019) (Circuit Judges Prost, Clevenger, and Wallach presiding; Opinion by...more
Case Name: Horizon Pharma, Inc. v. Dr. Reddy’s Labs., Inc., C.A. No. 15-3324 (SRC), -3326, -3327, 16-4918, -4920, -4921, -9035, 2018 U.S. Dist. LEXIS 196702 (D.N.J. Nov. 19, 2018) (Chesler, J.)....more
Case Name: Indivior Inc. v. Dr. Reddy’s Labs. S.A., No. 2018-2167, 2018 U.S. App. LEXIS 32776 (Fed. Cir. Nov. 20, 2018) (Circuit Judges Newman, Lourie, and Stoll; Opinion by Stoll, J.) (Appeal from D.N.J., McNulty, J.)....more
Case Name: Indivior Inc. v. Dr. Reddy’s Labs. S.A., No. 17-7111, 2018 U.S. Dist. LEXIS 116974 (D.N.J. July 13, 2018) (McNulty, J.)....more
Case Name: Eli Lilly & Co. v. Dr. Reddy’s Labs., Ltd., Civ. No. 16-0308-TWP-MPB, 2018 U.S. Dist. LEXIS 104653 (S.D. Ind. June 22, 2018) (Pratt, J.). Drug Product and Patent(s)-in-Suit: Alimta® (pemetrexed disodium); U.S....more
Case Name: Helsinn Healthcare S.A. v. Dr. Reddy’s Labs., Ltd., Nos. 14-4274 (SRC), -6341 (SRC) (Consol.) (D.N.J. Jan. 30, 2018) (Chesler, J.)....more
Case Name: Eli Lilly & Co. v. Dr. Reddy’s Labs., Ltd., Civ. No. 1:16-cv-00308-TWP-MPB, 2017 U.S. Dist. LEXIS 205578 (S.D. Ind. Dec. 14, 2017) (Pratt, J.)....more
Case Name: Genzyme Corp. v. Dr. Reddy’s Labs., Ltd., No. 16-2206, -2207, 2017 U.S. Fed. Appx. LEXIS 25454 (Fed. Cir. Dec. 18, 2017) (Circuit Judges Moore, Plager, and Chen presiding; Opinion by Chen, J.) (Appeal from D....more
Case Name: Horizon Pharma, Inc. v. Dr. Reddy’s Labs., Inc., 11-2317 (MLC) (DEA), 2017 U.S. Dist. LEXIS 107707 (D.N.J. July 12, 2017) (Cooper, J.). Drug Product and Patent(s)-in-Suit: Vimovo® (naproxen / esomeprazole...more
Case Name: Reckitt Benckiser Pharms., Inc. v. Dr. Reddy’s Labs. S.A., No. 14-1451-RGA, 2017 U.S. Dist. LEXIS 140633 (D. Del. Aug 31, 2017) (Andrews, J.). Drug Product and Patent(s)-in-Suit: Suboxone® (buprenorphine HCl /...more
Case Name: Helsinn Healthcare S.A. v. Dr. Reddy's Labs., Ltd., No. 12-2867 (MLC) (DEA), 2017 U.S. Dist. LEXIS 21477 (D.N.J. Feb. 14, 2017) (Cooper, J.). Drug Product and Patent(s)-in-Suit: Aloxi® (palonosetron); U.S....more